Structural biology meets data science: Does anything change? by Mura, Cameron et al.
  
 
 
Structural biology meets data science: Does anything change? 
 
 
 
Cameron Mura1,3, Eli J. Draizen1,3, and Philip E. Bourne1,2* 
 
 
 
Affiliations & correspondence 
1 Department of Biomedical Engineering; University of Virginia; Charlottesville, VA 22908; USA 
2 Data Science Institute; University of Virginia; Charlottesville, VA 22904; USA 
3 CM and EJD contributed equally to this work. 
* Corresponding author: Bourne, Philip E (peb6a@virginia.edu) 
 
Highlights & graphical abstract 
• Data science has emerged as a fourth 
paradigm of science, alongside the 
theoretical, experimental, and 
computational. 
• Structural biology’s rich history includes 
practices, such as an emphasis on 
openness and reproducibility, which can 
serve as positive models for many nascent 
areas of data science. 
• Machine learning is profoundly impacting 
the biosciences, based on recent literature 
trends; we are likely at the cusp of a gold 
rush moment in structural biology. 
 
Document information 
Last modified: 22 July 2018 [revised 29 August 2018] 
Running title: Structural Biology Meets Data Science 
Keywords: data science; machine learning; protein interactions, topic modeling 
Abbreviations: CNN, convolutional neural network; cryo-EM cryo‒electron microscopy; DL, deep 
learning; DS, data sciences; HPC, high-performance computing; ML, machine learning; 
NLP, natural language processing; NN, neural network; PDB, Protein Data Bank; PLI, 
protein•ligand interaction; PPI, protein•protein interaction; SW, software; TM, topic 
modelling; WMS, workflow management system. 
Additional notes: The main text is accompanied by 2 figures and 1 item of Supplementary Material. 
Journal info: Current Opinion in Structural Biology; October 2018; Biophysical and Computational 
Methods 
Current Opinion in Structural Biology Structural Biology Meets Data Science 
 
Mura, Draizen, and Bourne (2018) 1/15 
 
Abstract 
Data science has emerged from the proliferation of digital data, coupled with advances in algorithms, 
software and hardware (e.g., GPU computing).  Innovations in structural biology have been driven by 
similar factors, spurring us to ask: can these two fields impact one another in deep and hitherto 
unforeseen ways?  We posit that the answer is yes.  New biological knowledge lies in the relationships 
between sequence, structure, function and disease, all of which play out on the stage of evolution, and 
data science enables us to elucidate these relationships at scale.  Here, we consider the above question 
from the five key pillars of data science: acquisition, engineering, analytics, visualization and policy, with 
an emphasis on machine learning as the premier analytics approach. 
 
 
Introduction 
The term Structural Biology (SB) can be defined rather precisely as a scientific field, but Data Science (DS) 
is more enigmatic, at least currently.  The intrinsic difference is two-fold.  First, DS is a young field, so its 
precise meaning—based on what we practice and how we educate its practitioners—has had less time 
than SB [1,2] to coalesce into a consensus definition.  Second, and more fundamental, DS is 
interdisciplinary to an extreme; indeed, DS is not so much a field in itself as it is a way of doing science, 
given large amounts of diverse and complex data, suitable algorithms and sufficient computing resources.  
Such is the breadth and depth of DS that it has been described as a fourth paradigm of science, alongside 
the theoretical, experimental and computational [3,4].  Because it is so vast and sprawling, a helpful 
organizational scheme is to consider four V's and five P's that characterize data and DS (Figure 1). 
 The four V's describe the properties of data: volume, velocity, variety and veracity.  The P's are 
the five disciplinary pillars (P-i through P-v) of DS (Figure 1): (i) data acquisition, (ii) data reduction, 
integration and engineering, (iii) data analysis (often via machine learning), (iv) data visualization, 
provenance and dissemination, and (v) ethical, legal, social and policy-related matters.  The P's are 
interrelated, as are the V's.  For example, the fifth pillar leans into each of the other four: a host of privacy 
matters surround data acquisition, aggregation can have unforeseen security concerns, analytics 
algorithms can introduce unintended bias, and dissemination policies raise licensing and intellectual 
property issues.  Similarly, many modes of data analysis (P-iii) rely on advanced visualization approaches 
(P-iv).  The P's also closely link to the four V's.  For example, P-i, the data acquisition pillar, clearly relates 
to volume and velocity.  More subtle linkages also exist, e.g., between data analysis and variety: in 
structural biology, hybrid approaches [5-8] involve joint integration/analysis of heterogeneous varieties of 
data (e.g., cryo-EM, mass spectrometry, cross-linking), for instance via a Bayesian statistical formulation 
of the structure determination process [9,10].  The philosophy and epistemology of DS is an entire field 
unto itself, and helpful starting points can be found in recent texts [11]. 
 The rest of this review focuses on the junction of data science and structural biology.  We 
consider DS approaches that have been applied in SB recently, including examples from crystallography 
and protein interactions.  We focus mostly on pillar P-iii (Figure 1), and specifically machine learning.  In 
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so doing, we largely ignore traditional disciplinary labels.  For example, the junction of DS and SB could be 
viewed as simply expanding the field of structural bioinformatics [12]; but, such disciplinary labels and 
boundaries matter less than the actual scientific impact.  Analogously, definitions of "the internet" vary 
greatly, yet the impact of the internet on science is unmistakable.  For convenience, we use the term 'SB' 
as including structural bioinformatics, simply to distinguish what has gone before versus what may lie on 
the horizon.  We suspect much lies on the horizon: akin to the rapid growth [13] of databases such as the 
Protein Data Bank (PDB; [14]), our assessment of bibliometric data (Figure 2) suggests that data science 
will profoundly impact the biosciences, including structural biology. (The best-fit curve in Figure 2 is 
supra-exponential, with no inflection point in sight.)  Conversely, can SB impact the broader field of DS?  
This has yet to occur in a definitive way, but, given the maturity of SB as a discipline, much can be learnt 
from it and its history; thus, we start with a short review of how SB might influence DS. 
 
 
What structural biology has to offer data science 
Open science 
SB has pioneered open science through the provision of the PDB and many derivative data sources.  The 
complete corpus of structural information in the PDB is free of copyright and is available for unfettered 
use, non-commercial or otherwise (P-v).  Moreover, community practices—such as virtually no journal 
publishing an article without its data deposited in the PDB [15]—is  a precedent that, if broadly adopted 
in other disciplines, would deepen the amount and diversity of data available for DS-like approaches in 
those other scientific and technical domains.  The creation and free distribution of software (SW) tools 
has echoed this trend, as epitomized by the Collaborative Computational Project 4 (CCP4); developed and 
meticulously maintained since 1979 [16], the CCP4 suite has been a mainstay of the crystallographic 
structure-determination process.  CCP4 and kindred projects, alongside myriad other SW tools and 
attendant data, have fostered an open discipline.  DS draws upon data and ideas from a wide range of 
disciplinary areas, but some of these areas have been less open than SB, at least historically.  To succeed, 
we believe that any DS must abide by the 'FAIR' principles, enabling researchers to Find, Access, 
Interoperate and Reuse data and analytics [17].  SB has exercised this for decades, and is thus positioned 
to lead the way. 
Reproducibility 
In principle, reproducibility is the bedrock of the scientific enterprise.  And, as a byproduct of open 
science, reproducibility has been central in SB, though often less so in other realms of DS.  Cultural 
differences across various disciplines, often driven by (perceived) competitive pressures, have dampened 
what could be the norm.  In SB, the systematic, pipelined nature of many structure-determination 
approaches has facilitated reproducibility.  A notable example is the effort, spurred by structural 
genomics, to annotate large-scale macromolecular crystallization experiments and to conduct careful 
target tracking [18]; in principle, such efforts afford a rich source of data, exploitable by DS via data 
mining and machine learning methods [19]. 
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Workflows, high-performance computing 
Reproducibility, in turn, is facilitated by workflows.  Some workflow management systems (WMS) are 
domain-specific (e.g., Galaxy for genomics [20,21]), while others are more generic or monolithic (e.g., 
KNIME [22]); lightweight toolkits also exist, providing libraries to write custom parallel-processing 
pipelines (e.g., [23,24]).  Again, structural genomics and other data-rich areas (e.g., large-scale 
biomolecular simulations) have prompted the development of WMS solutions.  Closely related to 
workflows, recent technologies that have become best practices in DS—such as Jupyter notebooks (as a 
user interface) and Docker 'containers' (for virtualized runtime environments)—likely will be adopted 
more broadly in SB, as research questions become more quantitative and as data-intensive computational 
steps are pursued via distributed computing and other modes of HPC.  Cloud computing and related 
approaches, such as the MapReduce paradigm (implemented in Hadoop), rapidly entered genomics and 
bioinformatics early on [25] and are becoming more widely adopted in other biosciences too, including SB 
[26]; other examples include large-scale biomolecular modeling for virtual screening and drug design 
[27,28] and, more recently, cryo-EM pipelines for structure determination [29]. 
Structural biology has relied upon HPC since the dawn of supercomputing in the 1960s.  A recent 
example using HPC involves the phasing of diffraction data.  Recognizing the wealth of structural 
information in the PDB, and that molecular replacement (MR) can be treated as embarrassingly parallel 
across all these structures, the BALBES [30] pipeline leverages all known 3D structures to create and then 
use MR search models in an automated manner.  This approach was recently extended to fitting 3D 
models into cryo-EM maps [31].  Somewhat similar in spirit, PDB_REDO endeavors to automatically 
improve all PDB structures by re-refining 3D models against the original X-ray data, utilizing established 
refinement approaches (e.g., TLS) and grid computing [32,33].  As a final example, a recent and highly 
creative approach to crystallographic phasing has a strong DS feel: Encoding phase values as 9-bit strings 
(genes), and applying a genetic algorithm for sampling/optimization, Yeates & colleagues [34] developed 
a crowdsourced gaming platform for ab initio phasing, at least to low resolution.  Such 'citizen-science' 
[35,36] approaches will likely play broader roles in SB (and DS) in the coming decade. 
Visualization 
Visualization has played a key—indeed, defining—role in SB since the 1950s, when the first 
macromolecular structures were determined.  Concepts, principles and best practices for biomolecular 
visualization can be found in many reviews [37-39]; the supplement in [37] traces the historical 
development of this field.  Recent advances have occurred in web browser-embedded, hardware-
accelerated tools for interactive molecular visualization, such as the NGL Viewer [40]; in the future, a 
greater share of visualization work likely will occur within browsers.  To transcend how molecular 
renderings are usually communicated (as static images), we suspect that much could be gained by 
comparing visualization techniques in DS and SB.  Though iconic and highly informative, beware the 
"curse of the ribbon": macromolecules are dynamic, multifaceted entities, and static renditions are but a 
starting point.  For similar reasons, there is a need for molecular visualization platforms that transcend 
simple graphical viewers—that enable facile, flexible and extensible integration of other forms/modalities 
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of data and novel visualization techniques [41], such as the data-intensive sort that often arise with big 
data.  We believe that DS tools can address this need; note that texts are becoming available on this 
topic, such as the recent Big Data Visualization [42].  Ideas and methods from beyond SB—such as "chord 
diagram" layouts in genomics [43], termed "hierarchical edge bundles" [44] in computer graphics—can be 
applied in SB, for instance to visualize data associated with hierarchical clustering of protein structural 
differences (e.g., see the figures in [45]). 
Finally, note that further areas of SB×DS overlap can be identified, but are not treated here because 
of space limitations.  Three such examples are: (i) database (DB)-related issues, including structured 
versus unstructured data, relational versus non-relational DBs and query languages [46]; (ii) systems and 
network biology [47]; and (iii) ontologies and formal knowledge representation systems [48,49]. 
 
 
What data science analytics has to offer structural biology  
DS analytics spans a vast territory, including applied mathematics, statistics and computer science.  Here, 
we focus on two machine learning (ML) approaches—one which has received much recent attention 
(deep learning [DL]), and one for which we envision possible applications in SB (natural language 
processing [NLP]).  A glossary is included (Box 1), and the Supplementary Material offers: (i) a brief primer 
on ML, (ii) a concise historical note on early applications of neural networks in SB, and (iii) a short sketch 
of the general applicability of data sciences in structural biology and other biosciences. 
Machine learning applied to biomolecular interactions 
In a recent wave of activity, DL methods have been applied to model and predict protein•ligand and 
protein•protein interactions (PLI, PPI).  Deep learning is a type of ML that employs deep (multi-layered) 
neural network (NN) architectures; training and deploying such architectures is now feasible because of 
the exceptional computational performance of modern GPU-equipped clusters. 
Accurately predicting and modeling PLIs (structural poses, energetics) would advance many areas, 
both basic (e.g., evolutionary analyses of ligand-binding properties) and applied (e.g., drug design and 
discovery).  Historically, this field has largely relied on two distinct methodological approaches: 
quantitative structure-activity relationships (QSAR) and in silico docking.  Virtual screening, wherein one 
docks against large libraries of small compounds, is an established example of DS in SB; as a newer 
example, note that workflow-based approaches to high-throughput crystallographic fragment screening 
have a significant DS component [50].  Extensions of the basic QSAR and ligand-docking approaches also 
call upon DS.  For example, recognizing that a protein exists as an ensemble of thermally-accessible 
conformational states in solution, simulations have been combined with docking in the "relaxed complex" 
scheme to capture receptor flexibility [51].  Similar in spirit, data-intensive "ensemble-based" methods 
[52] can enable dynamic pharmacophore models (e.g., [53]) to be devised.  In a recent approach, a 
workflow to discover 'cryptic' (and druggable?) binding sites was developed by integrating comparative 
structural analyses, pocket-detection algorithms, fragment docking, molecular simulations, and an ML 
classifier [54].  In another data-driven, structure-based approach, Zhao et al. [55] recently analyzed the 
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human kinome by integrating ligand-binding data with protein-ligand "interaction fingerprints" and a 
sequence order-independent profile–profile alignment method ([56]; useful for determining specificity 
among similar ligand-binding sites). 
Recent work on predicting PLIs has directly employed ML, including for the interrelated goals of 
virtual screening, affinity prediction and pose prediction.  The application of statistical and ML approaches, 
in particular deep neural nets, to the PLI problem was reviewed recently [57].  Here, we mention only that 
a surge of new work has applied convolutional neural nets (CNNs) to the PLI problem—references [58-63] 
comprise a partial list from just the past year.  Notably, these purely ML-based approaches rely on human 
expertise only in the early stage of choosing structural descriptors (hydrophobicity, ionizability, etc.), 
which are input features for NN training.  The protein structure (either as a complex, or just receptor) can 
be treated as a 3D image, wherein atoms that compose the structure are assigned to discrete volumetric 
elements (voxels).  CNNs excel at learning from 2D image data [64], suggesting that their 3D counterpart, 
3D deep CNNs, can be used for volumetric analysis.  Leveraging these ideas, the 3D DCNN of DeepSite 
achieved state of the art performance, having been trained on known protein•ligand structures [58]. 
As with PLIs, protein•protein interactions (PPI) are critical to much of cell biology, and are another 
focal point of recent ML efforts.  Were all binary PPIs known, they could be used to build whole species 
interactomes [65] and inter-species (e.g., host-pathogen) interactomes [66,67], which, in turn, would aid 
elucidation of signaling pathways [68], metabolic networks (Recon3D [69]), and evolutionary pathways 
[70].  ML can be used to predict which two proteins interact and what specific residues ('hot-spots') 
mediate the interaction (i.e., binding sites).  If both binding sites (or interfaces) are known, they can be 
used to model structures of their complexes. 
Thus far, the optimal information for predicting interacting residues has been at the sequence level, 
using residue co-evolution.  Intuitively, residues that co-evolve between two proteins are likely to contact 
one another.  Such sites can be predicted using ML and DL methods like maximum entropy models or 2D-
CNNs [71-75]; a drawback to such approaches is the need for sufficiently large protein families.  For 
purposes of structure prediction, the same approach can be used to predict residue•residue contacts 
from one protein family alignment.  One can also predict PPIs from structure if a query protein is 
homologous (based either on sequence or structure) to one protein in a known PPI.  If the identity of only 
one interaction partner is known, and the binding sites in the other partner unknown, binding sites and 
partners can be predicted by structurally aligning a query to crystal structures of complexes, using either 
local (e.g., PRISM [76]) or global (e.g., IBIS [77]) 3D superimpositions.  Residues from the query protein 
that align to one side of an interface are predicted to be a part of the binding site. 
ML methods can also predict binding-site residues given the 3D structure of only one partner.  Here, 
atomic and residue-level features (e.g., hydrophobicity, phylogenetic conservation) are calculated for all 
structures in the PDB.  True binding site residues are taken from crystallized complexes, split into 
monomers, and used to train a classifier (SVMs, Decision Trees, etc.).  Unfortunately, such predictors have 
suffered from low precision and recall [78], perhaps because the 3D spatial details of the data are not 
retained but rather enter the model only as 'flattened' features (or, assumptions of independence are 
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applied incorrectly).  Given current limitations and difficulties, it is unsurprising that DL is now starting to 
be applied to PPI modeling and prediction.  While only biomolecular interactions are discussed here, we 
envision that contemporary DL approaches, such as variational autoencoders, will play major roles in 
areas such as structure prediction [79], protein design and evolutionary analyses [80]. 
Natural language processing applied to biomolecular assemblies 
NLP is a form of machine learning concerned with processing and analyzing language, written or spoken.  
Here, 'processing' can mean many things: analyzing frequencies and co-occurrences of words and higher-
order units (n-grams), parsing texts in syntactic/grammatical analyses, information retrieval, machine 
translation, language comprehension (and synthesis), and beyond.  The scope of this topic is vast, and 
helpful biosciences primers are available [81-83].  NLP methods play key roles in routine tasks such as 
search/query (databases, knowledge-bases), information extraction and text summarization; indeed, you 
may have reached this article via a web-query using the PubMed search engine.  PubMed is but one 
example of NLP in biomedical informatics, and it remains an active area of research; recent examples 
include a "neural word embedding" approach for document matching in PubMed [84] and development 
of a flexible term ↔ concept matching system for biomedical pipelines [85].  Apart from search and 
mining in biomedical literature, might NLP impact structural biology in other ways? 
NLP-like approaches have been applied to detect the subcellular localization of proteins [86,87] and, 
recently, to predict structures of protein complexes [88].  Notably, using ML–enhanced NLP, versus a 
purely text-mining–based NLP approach, was found to significantly improve the structural predictions of 
complexes [89].  Note that both sorts of problems—subcellular localization and structural modeling—are 
distinctly spatial, or image-based, as opposed to textual.  For this reason, we expect that a relatively new 
and highly-generalized approach to NLP, termed topic modeling (TM), holds great promise in the 
biosciences.  In TM, ‘topics’ are extracted over a corpus of unstructured data (e.g., a set of books) using a 
probabilistic machine learning framework; fundamentally, this is achieved by examining the distributions 
of words (a "bag of words" ansatz) under a generative statistical model, such as the latent Dirichlet 
allocation (LDA).  An introductory review of TM and a recent overview of TM-like approaches in 
bioinformatics can be found in refs [90] and [91], respectively.  To extend TM to other areas—including 
even the learning of topics (themes) from non-textual data like protein structures—the basic issue is one 
of defining a suitable mapping of one’s problem to TM’s core framework of document ↭ topic ↭ word.  
As a potential horizon, we suggest that TM may be applicable to the analysis of protein folds and other 
biomolecular structures.  Such an application of NLP to what is a fundamentally geometric problem finds 
precedent in the pioneering development of a generative Bayesian hierarchical model for scene 
classification from raw image data [92]. 
 
 
Conclusion 
In addressing the topic posed here—SB meets DS—we have considered the influences of these fields on 
one another, given their respective stages of maturity.  SB’s rich history could positively influence the five 
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pillars of DS (Figure 1).  For example, data collection and processing often entails well-established 
workflows, standards and practices (e.g., structure validation), such that the results (3D structures) can be 
taken as "gold standard" data in downstream analyses.  Moreover, SB uses some approaches, like 
ontologies (for standardization, automated relationship discovery), that are not as prevalent in DS, but 
which could enjoy broader application.  Notably, the data-access and software-sharing policies that have 
evolved in SB communities for decades can serve as positive models for DS. 
Conversely, DS is being driven by economic, political and social factors that reach far beyond science 
itself (technology, commerce, etc.), and which inspire scientists to further innovate across the five pillars 
of DS.  The links to SB are many and varied, and here we have touched on but two of them (ML more 
broadly, and NLP in particular).  Details of ML and NLP approaches are beyond the scope of this work, 
which has only sought to briefly sketch potential synergies between these DS-based approaches and SB. 
We answer our question, then, with a resounding yes: DS is already impacting SB, and we argue that 
the converse could be true, too.  The rate of change is less certain, but is clearly steep: Figure 2, based on 
the recent biosciences literature, suggests that we are at the cusp of a major impact.  Realizing the full 
benefits of this gold-rush moment will require more multidisciplinary training of students, support from 
scientific bodies, deep funding and, most importantly, a general willingness by the respective scientific 
communities.  These are interesting times indeed. 
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Glossary 
The following terms, organized here thematically, appear in this review or are pervasive in the literature.  
As part of the DS jargon, the terminology may be unfamiliar and is therefore included for convenience. 
Statistical and machine learning 
• Classifier: An algorithm or function that maps input data into one of at least two categories (or classes). 
For instance, if only two classes are possible (e.g., True or False, Even or Odd), and our input data are 
integers, then the modulo operation (mod 2) could serve as a binary classifier. 
• Model: A formal relationship between input data and some set of outputs; another way to view this is 
as a mapping, association rule or mathematical function.  As a concrete example, say we have an ideal, 
one-dimensional spring on a frictionless surface.  Say we collect dense (finely-sampled) data on the 
precise position (𝑥) of the spring’s terminus at many time-points (i.e., we have a time-series, {𝑥(𝑡)}).  To 
elucidate the system’s behavior in terms of our data, we may propose an equation, say the sinusoid 
𝑥(𝑡) = 𝐴 ⋅ cos(𝜔0𝑡 + 𝜙), where A is amplitude, 𝜙 is phase and 𝜔0 is angular frequency.  This functional 
form is what we mean by a model: the precise parameters will vary from system to system (different 
springs, stiffnesses, etc.), and what matters instead is the functional form of the mapping (in this case, 
the equation of motion models simple harmonic oscillation).  For more complex systems—e.g., 
recognizing patterns in images, delineating protein structures—such simple, closed-form expressions 
generally do not exist (nevermind us being able to propose them a priori!); statistical approaches come 
to the rescue by offering a way to learn a model for the set of input ↔ output associations. 
• Regression: A statistical approach to estimate relationships amongst variables; e.g., linear regression 
will estimate a linear relationship (or slope) between two or more variables, which can be used for 
purposes of prediction and classification. 
• Random forest: An ensemble of decision trees. 
• Decision trees: A classifier that follows if‒then‒else decision rules to traverse a directed graph, thus 
predicting an output.  The rules, or nodes of the tree, are the features of the model sorted by 
information gain when split on certain values of the features. 
• Supervised, unsupervised learning: See the Supplementary Material for a description of these terms. 
• Support vector machine (SVM): A classifier that finds a linear discriminatory boundary between classes, 
generally via regression in a higher-dimensional space or application of kernel methods (most simply, a 
'kernel' can be viewed as a measure of similarity between two feature sets, e.g., the dot product). 
Neural networks and deep learning 
• Neural network (NN): Also known as an 'artificial NN' or 'multilayer perceptron' in the older literature, 
these are mathematical networks of nodes, which are the processing units (loosely, neurons; also 
termed 'hidden units'), and edges, which link the nodes.  All NNs consist of at least two layers that 
interface with the environment: an input layer of nodes (receives input data) and an output layer (emits 
processed data [i.e., predictions, results]). 
• Feedforward NN: A NN architecture wherein information flows through the network unidirectionally, 
from the input layer to the output layer.  This is possible because the edges (links) are directed from 
one node to another; this network topology is a type of directed acyclic graph (DAG), and other DAG-
based NN architectures are conceivable. 
• Convolutional NN (CNN): A NN that applies convolutional operations, which take local, connected, sub-
regions of an input matrix as neurons. Inputs are typically 2D images, which is a 2D matrix of pixels, 
where the sub-regions are smaller pieces of the image, or 3D volumes where smaller cubes traverse the 
volume. 
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• Deep NN (DNN): Most simply, a NN architecture that includes multiple hidden layers. 
• Backpropagation: A method to update learnable weights of the NN interconnects between nodes by 
transmitting errors backwards (in the direction from the output layer towards the input layer); this 
backwards propagation of errors, in turn, corresponds to the network improving as a predictor, i.e., the 
network can be said to 'learn'. More concretely, backpropagation proceeds by applying the chain rule 
to compute the gradient of the error (the loss function) at each filter (node) for a given layer, and 
iteratively using the gradient values to update the weights; therefore, this is fundamentally a gradient 
descent algorithm, as found in many classes of optimization problems. 
• Loss function: A function to compute the error between the true and predicted values. For example, 
this could be as simple as the Euclidean distance between estimated and true (target) values. 
• Dropout: A technique to address overfitting by removing a randomly selected subset of nodes, in a 
single layer, during training (a forward and backward pass). This allows the NN to learn more robust 
features by testing different possible subsets of nodes; typically, on the order of 50% of nodes are 
silenced. 
• Regularization: A technique to optimally balance the perils of underfitting/overfitting to training 
datasets. 
• Epoch: One forward and one backward pass of all training data. Many epochs (typically ranging from 
30-1000) are usually required before a NN model converges. 
Natural language processing 
• Corpus: Most simply, a collection of information.  This term, prevalent in the NLP field, is frequently 
used to generically refer to written data (books, journals, etc.), where it often means a comprehensive 
collection on a particular topic (all writings by particular authors, or about a particular protein, etc.). 
• Topic: Most simply, a statistical distribution of words, each word being drawn from a well-defined set of 
words (a fixed vocabulary); a topic can also be viewed as a theme.  In many ways, a given document is 
defined by its collection of most prevalent topics. 
• Topic modeling (TM): A set of unsupervised algorithms to discover the topics in a corpus of 
(unstructured) information, generally by applying statistical algorithms to analyze and model word 
distributions. 
• Latent structure: A highly general concept, referring to there being some general correlation (or 
nonuniformity, or 'structure') among the hidden (latent) random variables that define the probabilistic 
distributions underlying models such as LDA. In TM, we seek to learn these relationships between 
hidden variables (i.e., the structure), which manifests in the form of (non-random) topics. 
• Latent Dirichlet allocation (LDA): A type of TM wherein a document (a "bag of words") is viewed as a 
probabilistic distribution over a set of topics; a topic, recall, is a distribution over words.  A rather 
involved generative statistical model underlies LDA; a 'generative' model means that the observed data 
(the document, its words, their distributions) are taken as having been generated via sampling a hidden 
distribution (a random process, or, if there is latent structure, a non-random process).  Briefly, each 
document’s set of topics are taken to be Dirichlet–distributed, and the words in a document are 
allocated to its various topics based on this distribution. (In the Bayesian sense of joint distributions, 
priors, etc., the Dirichlet distribution is the conjugate prior to the multinomial distribution that is taken 
as explaining the distribution of topics.) 
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Figure Captions 
 
Figure 1. SB mapped onto the five pillars of DS, and in relationship to the four V’s of big data.  DS rests 
upon five central pillars, schematized in (a) as (i) data acquisition; (ii) data integration & engineering; (iii) 
data analytics (e.g., machine learning); (iv) visualization, provenance and dissemination; and the (v) 
ethical, societal, legal and policy aspects.  General concepts and keywords from the data sciences are 
near the bottom of each column (e.g., MapReduce, a distributed computing paradigm), while more 
domain-specific examples rest atop each column (e.g., structure–based drug design [SBDD], middle 
column).  A band of opportunity arises as SB meets the data sciences.  Realizing these potential 
opportunities requires big data, which enables a question or system to be addressed via DS approaches 
like deep learning.  The four V’s of big data—volume, velocity, variety and veracity—are shown in (b), 
illustrated by vignettes from SB.  As indicated, the volume and velocity characteristics are intertwined; for 
instance, modern X-ray diffraction technologies enable shutter-less data collection, with upwards of many 
millions of diffraction patterns acquired per day (a concomitant increase in the rate of structure 
determination means growth in the volume of the PDB).  Fits of the data in the PDB histogram (b) to 
different functional forms—(i) a simple power law, (ii) a pure exponential, (iii) a stretched exponential and 
(iv) the product of an exponential and a power law—reveal form (iv) to be the best fit (orange trace). The 
Variety panel illustrates the challenge addressed by 'hybrid methods': data arise from cryo-EM, X-ray 
diffraction, NMR spectroscopy, molecular simulations, chemical cross-linking/mass spectrometry, 
phylogenetic analyses and a host of other potential approaches.  DS provides a framework for integrating 
such data in an optimal manner (in an information theoretic sense) so as to create 3D structural models. 
 
Figure 2. The recent surge in publishing activity for machine learning in the biosciences, shown here via 
bibliometric data obtained for the PubMed/MEDLINE (orange) and ISI Web of Science (blue) literature 
databases.  The overlaid histograms show the number of publications in which the string "machine 
learning" co-occurs in the title or abstract fields; the precise PubMed query was "machine 
learning[Title/Abstract]", and the string "machine learning AND bio*" was used for an ISI 
Topic search.  Both datasets were fit with the same four functions listed in Figure 1.  For both PubMed 
and ISI, a subtle crossover occurs wherein a supra-exponential (form iv) gives a better fit than a pure 
power law; such highly nonlinear 'J-curves' or 'hockey stick curves' arise in systems subject to singularly 
disruptive forces (e.g., human population growth after the Industrial Revolution, climate temperatures in 
the past century). Intriguingly, the approximate year of crossover—2010 for the ISI data, 2012 for 
PubMed—is generally regarded as the "breakthrough year" for Deep Learning (e.g., Google Brain learned 
a 'cat' de novo, from YouTube data), enabled by advances such as GPU computing, algorithmic 
approaches such as ReLU and 'dropout', and vast stores of labelled training data (ImageNet).  Judging by 
these charts, ML has begun driving a substantial transformation in the biosciences. 
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This Supplementary Material provides (i) a brief primer on machine learning, (ii) a concise historical 
note on early applications of neural networks in structural biology, and (iii) a short sketch of the gen-
eral applicability of machine learning/DS-based approaches in structural (and other) biosciences. 
 
A brief primer on machine learning 
Machine learning (ML) emerged from efforts in the artificial intelligence (AI) communities of the 1960s.  
With its possibilities and promises oversold, AI went on to largely languish in the ensuing decades.  A re-
surgence occurred in the foundations of statistical learning theories and algorithms in the 1980-90s; cou-
pled with advances in computing power in the past decade, this resurgence yielded a silent revolution in 
ML from the 1990s to the early 2000s.  ML has advanced so significantly in the past decade that, today, it 
is often taken as synonymous with AI.  Data-rich scientific disciplines, such as the biosciences (and par-
ticularly structural bioinformatics), have increasingly adopted ML approaches, driven by (i) improvements 
in algorithms, (i) software libraries and implementations that have become more accessible to non-
specialists, (iii) training data that have become richer in complexity and more abundant, and (iv) remarka-
ble strides in commodity computing power, chiefly via graphics processing units (GPUs) and approaches 
such as general-purpose computing on GPUs (GPGPU).  ML enjoys great visibility because of its successes 
in pattern recognition, computer vision, image classification, difficult games (e.g., Go [1], which has a high 
branching factor), and various types of natural language processing (information retrieval, machine trans-
lation, etc.).  The ability of an algorithm to 'learn' directly relates to the quality, complexity and availability 
of the data from which it learns.  As a cautionary note, life sciences data are complex, with many potential 
confounders; recognizing these limitations will enhance any application of ML to structural biology (SB). 
How do ML approaches 'work' to model a system?  (What it means, most generally, to 'model' a sys-
tem is described in the Glossary that accompanies the main text.)  First-principles, physically-grounded 
theories are intractable for systems as complex as those encountered in biology, and the core premise of 
ML is to take a wholly different approach.  Rather than force models on data (e.g., a harmonic oscillator 
to model bond vibrations), the approach is to allow models of a system to emerge (be learned) from the 
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data.  That is, the defining feature of ML is its focus on algorithms that can learn from (and make predic-
tions based on) data.  That is why ML is so central in data analytics. 
Data, in turn, are central in ML because they can be used in advanced statistical frameworks and 
probabilistic algorithms to model (or learn) literally any system [2].  More concretely, to 'model' means to 
learn some function, 𝑓, that maps 𝑓:𝒳 ↦ 𝒴.  With enough data and sufficient sampling, statistical meth-
ods can learn associations between inputs (𝒳) and outputs (𝒴).  Indeed, a sufficiently well-sampled sys-
tem can be viewed as nearly synonymous with the data describing it.  In addition to the basic statistical 
approaches to be applied, also required are: (i) large volumes of data, (ii) an objective/target function to 
train the ML system, sometimes referred to as a loss, cost, or fitness function, and (iii) an algorithm to 
sample the solution space, typically to find extrema of the objective function; the algorithm drives the key 
training/learning stage.  The word 'algorithm' is used in a quite general sense in ML: it can be conceptually 
straightforward, as with the idea of a genetic algorithm, or it may correspond to something fuzzier, such 
as the directional flow of information (data, weights, etc.) in a feed-forward neural network (NN).  In NNs, 
the network, with its weight update scheme and other parameters, is the algorithm.  In NNs, the learning 
algorithm often comes from a class of iterative optimization methods; stochastic gradient descent, with 
backwards propagation of errors ('backprop') to update weights, is one such training method.  Some of 
the terminology in this field is provided in an accompanying Glossary. 
A fundamental distinction between ML algorithms is whether they are supervised or unsupervised, 
and a related issue is labelled versus unlabelled data.  Systems typically analyzed by ML are characterized 
by data that populate high-dimensional, multi-parameter spaces (hence the need for big data).  A super-
vised learning method is trained against reliable, labelled data (e.g., if an image is a 'cat', 'lion', 'dog', etc.), 
and then the trained model can be used to classify unseen input data.  The two basic types of learning—
supervised and unsupervised—fall naturally along the labeled/unlabeled divide: a learning method is said 
to be supervised if it is trained against labelled target data prior to production usage (NNs are a prime ex-
ample), whereas an unsupervised algorithm or classifier 'learns' (detects) any inherent/latent structure in 
unlabelled input data (in addition to NNs, clustering is an example of an unsupervised approach often en-
countered in SB, e.g. [3]). 
 
Early applications of neural networks in structural biology: A concise historical note 
ML’s historical roots in AI reflected particular types of goals: major areas of early (and ongoing) activity 
included pattern recognition (e.g., in speech), computer vision, image classification, and information re-
trieval (text mining and related fields, such as machine translation).  Notably, the widely-recognized appli-
cations of neural networks and other ML approaches in those areas (see, e.g., [4] for an old review) were 
concurrent with many of the first forays of NNs in structural biology—early examples include the predic-
tions of protein secondary structures [5], transmembrane helices [6], signal peptides and other sorting 
signals [7], and subcellular localization of proteins [8]. 
 
General applicability of ML/DS-based approaches in structural (and other) biosciences: A short sketch 
The broad applicability and general efficacy of machine learning/data science–related approaches in 
structural biology is closely tied to one of the V’s of big data—namely, Variety.  Variety is easily under-
stood, though not often easily addressed, in structural biology. In short, variety refers to the various 
forms of data being considered (generated, transmitted, aggregated and otherwise processed).  A hall-
mark of modern, data-intensive analyses in structural biology, as well as other biosciences (and, indeed, 
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in any scientific or technical realm), is that the data are typically of multiple disparate types, and we seek 
a way to leverage the intrinsic information content of each of those types in order to achieve a goal—be 
it a decision (in business analytics or marketing) or an improved representation or model for a system (in 
structural biology).  The issue of types or modalities of data is crucial—how might one handle heteroge-
neous (and potentially large) sets of data?  Here, 'handle' does not mean simply the act of data-wrangling 
(a major effort in DS, in and of itself [9]), but rather how to most effectively 'combine' or utilize the vari-
ous types of data to allow one to formulate more complete, accurate and predictive models than would 
be otherwise possible (with only a single type of data/information)?  This, in essence, is arguably the key 
goal in all the various domains to which DS is applied: we want predictive models (actionable, and testa-
ble/verifiable/falsifiable).  Ideally, the models are interpretable, too, in terms of some underlying physical 
theory or molecular principles (that, indeed, is a gripe sometimes lodged against the 'black box' aspect of 
ML approaches such as neural networks).  This general topic is precisely where the variety ‘V’ of data sci-
ence  can flourish in structural biology and more broadly in the biosciences: a central characteristic of DS 
approaches (like most ML approaches) is that they generally provide a data-analysis/problem-solving 
framework that is highly generalized (agnostic of the particular problem domain), that is built upon a well-
principled statistical foundation (e.g., usage of maximum likelihood estimation in crystallographic phasing 
and refinement [10]), and that is abstracted away from the details of the particular problem at hand.  It is 
for this reason that, for instance, decision trees and random forests can be applied to problems as diverse 
as enzyme function prediction [11], structure-based prediction of protein-protein interfaces [12], and 
RNA splice-site recognition [13].  And, it is precisely this principle that makes data science so powerful for 
integrative/hybrid methods for structure determination. 
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